Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Role for Lyn tyrosine kinase as a regulator of stress-activated protein kinase activity in response to DNA damage.
Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease.
Regulation of gene expression by HIF-1.
Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation.
Will a 5-ASA a day keep the cancer (and dysplasia) away?
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Will a 5-ASA a day keep the cancer (and dysplasia) away?
Will a 5-ASA a day keep the cancer (and dysplasia) away? Am J Gastroenterol. 2005 Jun; 100(6):1354-6.
View in:
PubMed
subject areas
Anti-Inflammatory Agents, Non-Steroidal
Colitis, Ulcerative
Colorectal Neoplasms
Disease Progression
Humans
Mesalamine
Risk Factors
Treatment Outcome
authors with profiles
David T. Rubin